guest ::
| Home > Publications Database > Constitutive HIF-1α Expression in the Epidermis Fuels Proliferation and Is Essential for Effective Barrier Formation. > print |
| Home > Publications Database > Constitutive HIF-1α Expression in the Epidermis Fuels Proliferation and Is Essential for Effective Barrier Formation. > print |
| 001 | 279376 | ||
| 005 | 20250713001516.0 | ||
| 024 | 7 | _ | |a 10.1016/j.jid.2024.09.022 |2 doi |
| 024 | 7 | _ | |a pmid:39580109 |2 pmid |
| 024 | 7 | _ | |a 0022-202X |2 ISSN |
| 024 | 7 | _ | |a 1523-1747 |2 ISSN |
| 024 | 7 | _ | |a altmetric:172624268 |2 altmetric |
| 037 | _ | _ | |a DZNE-2025-00753 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Boix, Julia |b 0 |
| 245 | _ | _ | |a Constitutive HIF-1α Expression in the Epidermis Fuels Proliferation and Is Essential for Effective Barrier Formation. |
| 260 | _ | _ | |a Amsterdam |c 2025 |b Elsevier |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1752060711_17399 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Epidermis is one of the most rapidly proliferating tissues in the body with high demands for adenosine triphosphate and cellular building blocks. In this study, we show that to meet these requirements, keratinocytes constitutively express HIF-1α, even in the presence of oxygen levels sufficient for HIF-1α hydroxylation. We previously reported that mice with severe epidermal mitochondrial dysfunction actually showed a hyperproliferative epidermis but rapidly died of systemic lactic acidosis and hypoglycemia, indicating excessive glycolysis. In this work, we interrogated HIF-1α function in glycolysis by its epidermal ablation combined with mitochondrial dysfunction, which resulted in decreased proliferation but even earlier lethality due to a severe barrier defect. Our data demonstrate that HIF-1α is indispensable for maintaining a high aerobic glycolytic flux necessary for supplying energy but also for synthetizing cellular building blocks such as lipids, which are both essential for proliferation as well as barrier formation. HIF-1α is stabilized in keratinocytes in the presence of oxygen by high levels of HIF-1α transcripts, low levels of prolyl-4-hydroxylases (PHD2 and PHD3), and a low cellular a-ketoglutarate/lactate ratio, likely inhibiting prolyl-4-hydroxylase activity. Our data suggest a key role for constitutive HIF-1α expression allowing a Warburg-like metabolism in healthy, highly proliferative keratinocytes, similar to that in tumor cells. |
| 536 | _ | _ | |a 351 - Brain Function (POF4-351) |0 G:(DE-HGF)POF4-351 |c POF4-351 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a Epidermal barrier function |2 Other |
| 650 | _ | 7 | |a HIF-1α |2 Other |
| 650 | _ | 7 | |a Lipid synthesis |2 Other |
| 650 | _ | 7 | |a Mitochondrial DNA |2 Other |
| 650 | _ | 7 | |a Skin homeostasis |2 Other |
| 650 | _ | 7 | |a Hypoxia-Inducible Factor 1, alpha Subunit |2 NLM Chemicals |
| 650 | _ | 7 | |a Hif1a protein, mouse |2 NLM Chemicals |
| 650 | _ | 2 | |a Hypoxia-Inducible Factor 1, alpha Subunit: metabolism |2 MeSH |
| 650 | _ | 2 | |a Hypoxia-Inducible Factor 1, alpha Subunit: genetics |2 MeSH |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Cell Proliferation |2 MeSH |
| 650 | _ | 2 | |a Mice |2 MeSH |
| 650 | _ | 2 | |a Epidermis: metabolism |2 MeSH |
| 650 | _ | 2 | |a Epidermis: pathology |2 MeSH |
| 650 | _ | 2 | |a Keratinocytes: metabolism |2 MeSH |
| 650 | _ | 2 | |a Keratinocytes: cytology |2 MeSH |
| 650 | _ | 2 | |a Glycolysis |2 MeSH |
| 650 | _ | 2 | |a Mitochondria: metabolism |2 MeSH |
| 700 | 1 | _ | |a Knuever, Jana |b 1 |
| 700 | 1 | _ | |a Niehoff, Nadine |b 2 |
| 700 | 1 | _ | |a Sen, Ayesha |b 3 |
| 700 | 1 | _ | |a Pla-Martin, David |b 4 |
| 700 | 1 | _ | |a Baris, Olivier R |b 5 |
| 700 | 1 | _ | |a Etich, Julia |b 6 |
| 700 | 1 | _ | |a Brachvogel, Bent |b 7 |
| 700 | 1 | _ | |a Kaul, Harshita |b 8 |
| 700 | 1 | _ | |a Isbrandt, Dirk |0 P:(DE-2719)2810976 |b 9 |u dzne |
| 700 | 1 | _ | |a Soroka, Ekaterina |b 10 |
| 700 | 1 | _ | |a Bazzi, Hisham |b 11 |
| 700 | 1 | _ | |a Wenger, Roland H |b 12 |
| 700 | 1 | _ | |a Giavalisco, Patrick |b 13 |
| 700 | 1 | _ | |a Wiesner, Rudolf J |b 14 |
| 773 | _ | _ | |a 10.1016/j.jid.2024.09.022 |g Vol. 145, no. 7, p. 1683 - 1692.e8 |0 PERI:(DE-600)2006902-9 |n 7 |p 1683 - 1692.e8 |t The journal of investigative dermatology |v 145 |y 2025 |x 0022-202X |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/279376/files/DZNE-2025-00753.pdf |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/279376/files/DZNE-2025-00753.pdf?subformat=pdfa |
| 909 | C | O | |o oai:pub.dzne.de:279376 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)2810976 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-351 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Brain Function |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2024-12-11 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J INVEST DERMATOL : 2022 |d 2024-12-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-11 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-11 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2024-12-11 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b J INVEST DERMATOL : 2022 |d 2024-12-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2024-12-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-11 |
| 920 | 1 | _ | |0 I:(DE-2719)1011003 |k AG Isbrandt |l Experimental Neurophysiology |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1011003 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|